| Schedule of Unaudited Interim Condensed Balance Sheets |
UNAUDITED INTERIM CONDENSED BALANCE SHEETS (All amounts are in USD, except for share and per share data, unless otherwise noted) | | | December 31, | | | June 30, | | | | | 2025 | | | 2026 | | | | | | | | (Unaudited) | | | Assets | | | | | | | | Current assets | | | | | | | | Cash and cash equivalents | | $ | 1,179,880 | | | $ | 650,425 | | | Financial assets held for trading | | | 1,435,901 | | | | 1,435,901 | | | Advance to related party | | | 19,964 | | | | 19,964 | | | Other current assets | | | 530,000 | | | | 20,606,000 | | | Total Current Assets | | $ | 3,165,745 | | | $ | 22,712,290 | | | Non-current assets | | | | | | | | | | Investment in subsidiary | | | 2,483,593 | | | | 933,263 | | | Other non-current assets | | | 600,000 | | | | - | | | Total Non-current Assets | | | 3,083,593 | | | | 933,263 | | | Total Assets | | $ | 6,249,338 | | | $ | 23,645,553 | | | Liabilities and Equity | | | | | | | | | | Current Liabilities | | | | | | | | | | Accounts payable | | | 55,336 | | | | - | | | Due to subsidiary | | | 71,035 | | | | 71,035 | | | Total Current Liabilities | | $ | 126,371 | | | $ | 71,035 | | | Total Liabilities | | $ | 126,371 | | | $ | 71,035 | | | COMMITMENTS AND CONTINGENCIES | | | | | | | | | | Shareholders’ Equity | | | | | | | | | | *Class A ordinary shares, $0.0001 par value, 400,000,000 shares authorized, 9,382,000 and 109,382,000 shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively | | $ | 938 | | | $ | 10,938 | | | *Class B ordinary shares, $0.0001 par value, 100,000,000 shares authorized, 7,668,000 shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively | | | 767 | | | | 767 | | | Additional paid-in capital | | | 11,700,497 | | | | 34,991,640 | | | Statutory reserves | | | 89,685 | | | | 89,685 | | | Accumulated deficit | | | (5,620,752 | ) | | | (11,476,168 | ) | | Accumulated other comprehensive loss | | | (48,168 | ) | | | (42,344 | ) | | Total Shareholders’ Equity | | $ | 6,122,967 | | | $ | 23,574,518 | | | Total Liabilities and Shareholders’ Equity | | $ | 6,249,338 | | | $ | 23,645,553 | | | * | Giving retroactive effect to the re-denomination and nominal issuance of shares effected on March 23, 2023. |
|
| Schedule of Unaudited Interim Condensed Statements of Operations and Comprehensive Loss |
UNAUDITED INTERIM CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (All amounts are in USD, except for share and per share data, unless otherwise noted) | | | Six Months | | | Six Months | | | | | Ended | | | Ended | | | | | June 30, | | | June 30, | | | | | 2025 | | | 2026 | | | | | (Unaudited) | | | (Unaudited) | | | General and administrative expenses | | | (1,825,351 | ) | | | (3,773,685 | ) | | Research and development | | $ | - | | | $ | (525,000 | ) | | Loss from operations | | | (1,825,351 | ) | | | (4,298,685 | ) | | Other loss | | | 27,204 | | | | (577 | ) | | Loss from subsidiaries | | $ | (239,349 | ) | | $ | (2,483,429 | ) | | Net loss | | $ | (2,037,496 | ) | | $ | (6,782,691 | ) | | Foreign currency translation adjustments | | | (1,346 | ) | | | 5,824 | | | Comprehensive Loss | | $ | (2,038,842 | ) | | $ | (6,776,867 | ) |
|
| Schedule of Unaudited Interim Condensed Statements of Cash Flows |
UNAUDITED INTERIM CONDENSED STATEMENTS OF CASH FLOWS (All amounts are in USD, except for share and per share data, unless otherwise noted) | | | Six Months | | | Six Months | | | | | Ended | | | Ended | | | | | June 30, | | | June 30, | | | | | 2025 | | | 2026 | | | | | (Unaudited) | | | (Unaudited) | | | CASH FLOWS FROM OPERATING ACTIVITIES | | | | | | | | Net cash used in operating activities | | $ | (2,715,600 | ) | | $ | (529,455 | ) | | Net cash used in investing activities | | $ | (1,660,000 | ) | | $ | (20,000,000 | ) | | Net cash provided by financing activities | | $ | - | | | $ | 20,000,000 | | | CHANGES IN CASH AND CASH EQUIVALENTS | | | | | | | | | | Net decrease in cash and cash equivalents | | $ | (4,375,600 | ) | | $ | (529,455 | ) | | Cash and cash equivalents at beginning of the period | | | 6,052,260 | | | | 1,179,880 | | | Cash and cash equivalents at end of the period | | $ | 1,676,660 | | | $ | 650,425 | |
|